Related Experiment Videos
Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique
A G Little1, A DeHoyos, D M Kirgan
1University of Nevada School of Medicine, Department of Surgery, Las Vegas, Nev., USA.
The Journal of Thoracic and Cardiovascular Surgery
|January 27, 1999
Summary
The sentinel node technique using isosulfan blue dye is a feasible method for lymphatic mapping in non-small cell lung cancer surgery. This technique shows good specificity in identifying N0 cases, but further research is needed to define its role in detecting advanced disease.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Staging
Background:
- Accurate staging of lymph node metastasis is critical for non-small cell lung cancer (NSCLC) treatment.
- The sentinel lymph node (SLN) technique offers a potential method for precise nodal staging.
Purpose of the Study:
- To evaluate the accuracy and clinical utility of the sentinel node technique in NSCLC patients.
- To assess the SLN's ability to predict the status of other lymph node stations.
Main Methods:
- 36 NSCLC patients undergoing lung resection were studied.
- Isosulfan blue dye was used for peritumoral injection to identify the SLN.
- Sensitivity and specificity of SLN biopsy for nodal staging were calculated.
Main Results:
- Sentinel lymph nodes were identified in 17 patients; 9 had no metastasis.
- Unexpected N2 disease was detected in 5 patients with mediastinal SLNs.
- No SLN was found in 19 patients, with final nodal statuses N0 (13), N1 (5), and N2 (1).
Conclusions:
- Intraoperative lymphatic mapping with isosulfan blue is feasible in NSCLC surgery.
- The SLN technique demonstrated good specificity, accurately identifying N0 disease in 9/9 patients.
- Further experience is required to fully establish the SLN technique's role in NSCLC management, especially for detecting unexpected advanced nodal disease.